Psilocybin, commonly known as the psychedelic substance found in magic mushrooms, has a long history of use for its therapeutic potential. It has been studied for its potential to treat severe depression, post-traumatic stress disorder (PTSD), end-of-life anxiety among the terminally ill, and some mental health conditions.
While it is still outlawed at the federal level, in 2018 the Food and Drug Administration (FDA) granted psilocybin mushrooms “breakthrough therapy” status for major depressive disorder. This led to clinical trials that tested the effects of psychedelics on people’s mental health. Oregon recently made history by becoming the first state in America to legalize the therapeutic use of psilocybin.
Four different types of licenses will be issued: manufacturing, laboratories, service centers, and facilitators.
The legalization of this program has been celebrated by advocates who believe in the therapeutic potential of psychedelics. One of them is InnerTrek, a Portland-based organization that offers courses to teach students how to accompany psilocybin patients during their psychedelic experiences.
Additionally, Psychedelic Medicine PAC was formed earlier this month; it is dedicated to supporting candidates for office who advocate for the therapeutic use of psychedelics.
Oregon’s Historic Move to Legalize the Use of Psilocybin Products for Therapy
Oregon’s historic move to legalize psilocybin products is a major milestone in the push for greater access and acceptance of psychedelics for therapeutic purposes. Last week, Oregon regulators issued the state’s first business license under its established psilocybin therapy program to Satori Farms PDX LLC, allowing them to begin manufacturing and distributing psilocybin products. This marks an important step towards normalizing psychedelic therapy and increasing accessibility in Oregon.
The entire process began when voters approved the system during the 2020 election, officially launching this January under Oregon Psilocybin Services — a branch of the Oregon Health Authority.
First Business License Issued by Oregon Health Authority to Satori Farms PDX LLC
The first business license was issued last week by the Oregon Health Authority under its established psilocybin therapy program to Satori Farms PDX LLC—making it the first in the nation to be granted this privilege. The license allows Satori Farms PDX LLC to begin manufacturing and distributing psilocybin products, a major milestone for Oregon.
The launch of this program has been met with great enthusiasm by advocates. One of them is InnerTrek, a Portland-based organization that provides training programs to prepare facilitators to accompany psilocybin patients during their experiences. It has also seen the formation of the Psychedelic Medicine PAC, which supports candidates for office who advocate for the therapeutic use of psychedelics.
Oregon’s historic move to legalize psilocybin opens up new possibilities for those in Oregon and individuals around the country looking for alternative options for mental health treatment. This license provides hope to many that psychedelics can be used safely and responsibly to treat various illnesses and conditions.
InnerTrek Training Program Completion – Preparing Oregon Facilitators to Accompany Psilocybin Patients During Their Experiences
One of the biggest proponents of Oregon’s historic move to legalize psilocybin products is InnerTrek. This Portland-based organization offers courses to teach facilitators how to accompany psilocybin patients during their psychedelic experiences. The program includes a completion certificate after the training sessions and course material, which can be used to apply for a facilitator or service provider license under Oregon Psilocybin Services.
The program covers safety protocols, dosage recommendations, legal and ethical considerations, fostering an optimal set and setting for psychedelic experiences, integrating experiences after the session, and more. The InnerTrek team has also developed a network of resources and services to provide additional support to those who have completed their training program.
InnerTrek’s commitment to providing comprehensive training to ensure responsible psilocybin use makes them a valuable partner in advancing access and acceptance of this powerful therapeutic tool. Their dedication to educating facilitators on how to safely accompany patients through the process of healing with psychedelics is an important step towards normalizing psychedelic therapy and increasing accessibility in Oregon.
Formation of Psychedelic Medicine PAC to Support Candidates for Office Who Advocate for Therapeutic Use of Psychedelics
In recognition of the importance of this historic move in Oregon, a new political action committee (PAC) has been formed called the Psychedelic Medicine PAC. This PAC is dedicated to supporting candidates for office who advocate for the therapeutic use of psychedelics and believe that access to these powerful transformative tools should be available to all who need it.
The formation of this PAC demonstrates the community’s commitment to making psilocybin therapy accessible in Oregon and nationwide. It is an exciting development as it signals a shift in how society views psychedelic medicine and how far we have come since its criminalization decades ago. With committees like this in place, we can be sure that the future of psychedelic therapy expands access and normalizes its responsible use.
Enjoyed that first hit? Come chill with us every week at the Friday Sesh for a freshly packed bowl of the week’s best cannabis news!